Skip to main content

More fat cells, less fat?

A fat-based hormone, the first of its kind to be identified, may regulate the body's metabolic rate, according to a linkurl:report;https://www.cell.com/content/article/abstract?uid=PIIS0092867408010143 in this week's __Cell.__ The results paradoxically suggest that aspects of metabolic disease could be controlled by spurring the production of new fat cells. "There's a strong dogma that excess fat is bad in every form, that the effects will always be negative," said principal investigator Gokhan

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
A fat-based hormone, the first of its kind to be identified, may regulate the body's metabolic rate, according to a linkurl:report;https://www.cell.com/content/article/abstract?uid=PIIS0092867408010143 in this week's __Cell.__ The results paradoxically suggest that aspects of metabolic disease could be controlled by spurring the production of new fat cells. "There's a strong dogma that excess fat is bad in every form, that the effects will always be negative," said principal investigator Gokhan Hotamisligil from the Harvard School of Public Health. "In these animals the hypothesis did not hold up." Hotamisligil and colleagues were studying lipid chaperones, which control the storage of fat inside cells. When they created knockout mice missing two of the chaperones, they saw systemic changes in metabolism as well as increased production of new fat cells. Since the new fat seemed to be causing changes in insulin sensitivity in organs such as muscle and liver, the researchers suspected it was releasing a hormone that traveled to these distant organs to cause an effect. Their search for the hormone, however, was "not fruitful," Hotamisligil told __The Scientist.__ In a last ditch effort, they decided to look at the lipid dissolved in the blood. While it's known that fat tissue produces hormones and that signaling proteins help regulate metabolism, lipids have not traditionally been thought of as signaling molecules (read our September 2007 feature on fat signaling molecules linkurl:here.;https://www.the-scientist.com/article/display/53541/ ) What made the experiments difficult, said Hotamisligil, is that, "Lipids are nasty molecules to work with." Techniques that have allowed large-scale analysis of genes and proteins are not prevalent in lipid research, so first author Haiming Cao and colleagues had the laborious task of characterizing the lipid fraction by liquid and gas chromatography and mass spectrometry of more than 400 lipid species. One lipid stood out in their analyses: C16:1n7-palmitoleate. In mice, the researchers found, the substance acted like insulin. "It potentiates insulin action and allows it to signal much better," said Hotamisligil. Palmitoleate may seem like an attractive target for those suffering from metabolic diseases such as diabetes, but administered directly, it "may not establish continuous efficacy," said Hotamisligil. Instead he thinks that new fat cell formation, which naturally increases palmitoleate levels, could lead to better control of insulin and possibly linkurl:decreased body weight.;https://www.the-scientist.com/2008/01/1/28/1/ That means the two lipid chaperones the researchers started with may provide better targets. "This is a very interesting and provocative study," wrote Alan Attie, a professor of metabolic diseases at the University of Wisconsin-Madison who was not involved in the work. He added that it "raises many questions that will keep people busy for quite some time," such as identifying the tissues that produce palmitoleate, and the tissues it targets to induce the insulin sensitivity boost.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • The Scientist Placeholder Image

    Edyta Zielinska was a senior editor at The Scientist from 2007 to 2013, where she worked closely with scientific illustrators to develop accompanying graphics to illuminate complex concepts. 

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Qiagen Logo
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays